656 related articles for article (PubMed ID: 17714422)
1. Detection of anti-D in D- recipients transfused with D+ red blood cells.
Yazer MH; Triulzi DJ
Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
[TBL] [Abstract][Full Text] [Related]
2. Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization.
Yazer MH; Triulzi DJ
Am J Clin Pathol; 2010 Sep; 134(3):443-7. PubMed ID: 20716801
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
Natukunda B; Schonewille H; van de Watering L; Brand A
Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients.
Gonzalez-Porras JR; Graciani IF; Perez-Simon JA; Martin-Sanchez J; Encinas C; Conde MP; Nieto MJ; Corral M
Transfusion; 2008 Jul; 48(7):1318-24. PubMed ID: 18422846
[TBL] [Abstract][Full Text] [Related]
5. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
[TBL] [Abstract][Full Text] [Related]
6. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
Schonewille H; van de Watering LM; Brand A
Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
8. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
Yazer MH; Triulzi DJ; Shaz B; Kraus T; Zimring JC
Transfusion; 2009 Jun; 49(6):1070-5. PubMed ID: 19309468
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
Tormey CA; Fisk J; Stack G
Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
[TBL] [Abstract][Full Text] [Related]
10. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
[TBL] [Abstract][Full Text] [Related]
11. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
12. A case for stocking O D+ red blood cells in emergency room trauma bays.
Meyer E; Uhl L
Transfusion; 2015 Apr; 55(4):791-5. PubMed ID: 25444310
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization to red cell antigens in liver and multivisceral transplant patients.
Shariatmadar S; Pyrsopoulos NT; Vincek V; Noto TA; Tzakis AG
Transplantation; 2007 Aug; 84(4):527-31. PubMed ID: 17713438
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion.
Yazer MH; Brunker PA; Bakdash S; Tobian AA; Triulzi DJ; Earnest V; Harris S; Delaney M
Transfusion; 2016 Oct; 56(10):2502-2509. PubMed ID: 27401270
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
18. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients.
Friese RS; Sperry JL; Phelan HA; Gentilello LM
Am J Surg; 2008 Jul; 196(1):56-61. PubMed ID: 18513694
[TBL] [Abstract][Full Text] [Related]
19. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).
Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A
Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
